The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I think the imbalance is due to the nature of this product, when people buy something especially that is a little taboo, they wont go on to say they had a wonderful night and hard for hours, they'll buy it again and again without posting a review, why would they? The reason its super negative is because the others have spent £25 on what they deem has done nothing and therefore want to complain. I mean there is 319 negative reviews on boots 2* and below, how many do you think boots have sold? I imagine and hope its thousands. I do agree though it is very annoying that potentially a great product looks poor because of the 30% it doesn't work for. lets hope the rest of the paying public will try it regardless.
I think this will keep yo-yo’ing until cooper either complete their European product launch and or FDA approval has been granted, anyone who sells now is clearly in it for the short term, and fair play, but there is huge upside to this price at present. The ED market is currently worth circa $3.6bn. I think after the EU and South American roll out + FDA approval, this will be easily worth 1.20-1.40.
The product is still not showing on Coopers home page https://www.cooperconsumerhealth.eu/our-brands/
We have approval though, just not in the states, which granted is the biggest market.. I am surprised they are selling without any launch in Europe. I would expect the marketing to be on posters in tube stations, tube trains, rest rooms at motorway service stations etc, etc. Does anybody know exactly what the deal with cooper said regarding marketing? Will they complete all marketing or a %, is it linked to FDA, etc?
My research previously of FDA Timescales was not encouraging, most applications took longer that 9 months till decision, The focus for 2023 should be on the European soft launch that cooper are in the throws of now. Early uptake and sales through Cooper should put us into the £1 territory
IMO for £2 to be breached there would need to be some sizeable sales and US approval and partner signed, I think 90p - £1 in the next 6 months is more realistic.
Good find on the webinar, they most likely may be having two separate launches for UK and EU.
Everyone has FOMO, hopefully the next few weeks sets a new resistance at 50+. There was always going to be some selling following the recent RNS, I think that has concluded now and hopefully we should see a steady ship and maybe gradual rise over the next few months.